Abstract

IntroductionThe hobnail variant of papillary thyroid cancer (PTC) is rare. Intrathyroid parathyroid adenoma (ITPA) is also rare. Co-ocurrence of PTC and ITPA in the same thyroid lobe is extremely rare. Likewise, primary hyperparathyroidism with such non-medullary thyroid carcinoma is rare. The specific molecular profile of hobnail PTC (HPTC) is different from the classic, poorly differentiated and anaplastic variants and may contribute to its aggressive behavior. HPTC’s genetic profile remains unclear. Presentation of caseA 61-year-old woman presented to our endocrine clinic with generalized aches, bone pain, polyuria, and right neck swelling of a few months’ duration. Laboratory findings revealed hypercalcemia and hyperparathyroidism. Ultrasound of the neck showed 4.6 cm complex nodule within the right thyroid lobe. Sestamibi scan suggested parathyroid adenoma in the right thyroid lobe. Fine-needle aspiration (FNA) revealed atypical follicular lesion of undetermined significance. She underwent right lobectomy, which normalized the intraoperative intact parathyroid hormone levels. Final pathology with immunohistochemical stains demonstrated HPTC and IPTA (2 cm each). Next-generation sequencing investigated the mutation spectrum of HPTC and detected BRAFV600E mutation. ConclusionsA parathyroid adenoma should not exclude the diagnosis of thyroid carcinoma. Thyroid evaluation is needed for patients with primary hyperparathyroidism to prevent missing concurrent thyroid cancers. Cytomorphologic features to distinguish thyroid from parathyroid cells on FNA cytology must be considered. Immunohistochemical stains are important. BRAFV600E is the most common mutation in HPTC. This is possibly the first reported case of HPTC and ITPA co-occurring within the same thyroid lobe. Studies that define other molecular abnormalities may be useful as therapeutic targets.

Highlights

  • The hobnail variant of papillary thyroid cancer (PTC) is rare

  • This paper reports the first case of co-occurrence of hobnail PTC (HPTC) and Intrathyroid parathyroid adenoma (ITPA) in the same thyroid lobe and further defines the clinical/molecular characteristics of HPTC that may be useful for prognostic stratification and may provide therapeutic targets

  • Conventional neck exploration did not reveal the Parathyroid adenoma (PA), and surgery proceeded with right hemithyroidectomy as planned, which was followed by a sudden drop of intraoperative rapid PTH (94.3% drop from pre-incision serum baseline, confirming excision of ITPA)

Read more

Summary

INTRODUCTION

The hobnail variant of papillary thyroid cancer (PTC) is rare. Co-ocurrence of PTC and ITPA in the same thyroid lobe is extremely rare. Primary hyperparathyroidism with such non-medullary thyroid carcinoma is rare. The specific molecular profile of hobnail PTC (HPTC) is different from the classic, poorly differentiated and anaplastic variants and may contribute to its aggressive behavior. Sestamibi scan suggested parathyroid adenoma in the right thyroid lobe. Fineneedle aspiration (FNA) revealed atypical follicular lesion of undetermined significance. She underwent right lobectomy, which normalized the intraoperative intact parathyroid hormone levels. BRAFV600E is the most common mutation in HPTC This is possibly the first reported case of HPTC and ITPA co-occurring within the same thyroid lobe. Studies that define other molecular abnormalities may be useful as therapeutic targets

Introduction
Patient presentation
Parathyroid sestamibi scan
Cytopathology
Surgical technique
Final histopathology of right thyroid lobe
Immunohistochemical stains
Follow up
Discussion
Conclusion
Findings
Declaration of Competing Interest
Ethical approval
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.